Bayer Aktiengesellschaft (ETR:BAYN) Trading Down 0.3% - Should You Sell?

Key Points

• Bayer Aktiengesellschaft (ETR:BAYN) experienced a 0.3% decrease in its stock price, trading at €27.26 ($31.69) on Thursday.
• The company has a market cap of $27.52 billion and operates in life sciences through its Pharmaceuticals, Consumer Health, and Crop Science segments.
• Its price-to-earnings ratio stands at -31.27, indicating a negative earnings metric, while the price-to-earnings-growth ratio is at 36.39.

Bayer Aktiengesellschaft (ETR:BAYN - ) traded down 0.3% on Thursday . The company traded as low as €27.14 ($31.55) and last traded at €27.26 ($31.69). 1,604,780 shares were traded during trading, The stock had previously closed at €27.33 ($31.78).

Bayer Aktiengesellschaft Trading Down 0.3%

The business has a 50 day simple moving average of €27.72 and a two-hundred day simple moving average of €25.81. The stock has a market cap of $27.52 billion, a price-to-earnings ratio of -31.27, a price-to-earnings-growth ratio of 36.39 and a beta of 0.97.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.